W R Berkley Corp reported fourth-quarter earnings of $1.13 per share, in line with expectations, while sales of $3.721 billion exceeded estimates. Despite positive sales results, the stock fell 0.4% as analysts lowered price targets, signaling cautious sentiment going forward.
WR Berkley will report Q3 earnings on Oct. 20, expected at $1.10/share. Revenue estimate for Q3 is $3.15 billion, up from $2.93 billion. UBS analyst raised price target to $87, maintaining a Buy rating. Wells Fargo increased the price target to $69 with an Equal-Weight rating. Stock closed at $74.05, gaining 0.5% on Friday.
W. R. Berkley reported increased second-quarter profit, driven by strong investment gains. Steady underwriting performance contributed to the positive financial results.
W.R. Berkley shares hit a record high following MSI's investment news. Mitsui Sumitomo Insurance aims for a 15% stake by March 2026. MSI will vote in favor of Berkley family recommendations initially. Berkley family plans to retain significant ownership and board representation. The investment will not affect daily operations of W.R. Berkley.
WR Berkley shares rose over 7% following strong Q3 earnings. Goldman Sachs predicts continued strong casualty pricing until 2025. Analyst upgraded WRB to Buy, maintaining a $69 price target. WRB likely to maintain insurance pricing above claims, enhancing margins. Increased premium growth expected from the E&S market, boosting WRB.
W.R. Berkley (WRB) has a Zacks Rank of #3 (Hold). WRB's forward P/E ratio is 13.41, indicating attractive valuation. Analysts raised WRB's earnings estimate to $3.89 per share. WRB shows an average earnings surprise of 11.4%. The company has strong Value and VGM Style Scores.